PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Nicotine Withdrawal in the ICU: Evidence Too Thin for Routine NRT

nicotine replacement therapytransdermal nicotinenicotine dependencenicotine withdrawal syndromedeliriumagitationintensive care unitcritical carescoping reviewsmoking cessationsedation management Critical Care / ICU

Background Information

Nicotine withdrawal may worsen ICU outcomes without clear treatment protocols.

Nicotine withdrawal in the ICU can complicate treatment due to both psychological and somatic factors. The study found that delirium, agitation, and anxiety are common in ICU patients with nicotine withdrawal, but diagnostic and treatment approaches are inconsistent. Identifying nicotine dependence and monitoring for withdrawal in ICU patients is crucial, although current interventions like nicotine replacement therapy (NRT) lack robust efficacy data. Monitor ICU patients for nicotine withdrawal and individualize sedation and NRT approaches cautiously.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Piotrkowska R, Miszewska A, Lange S, Mędrzycka-Dąbrowska W, Krupa-Nurcek S

Citation: Piotrkowska R, Miszewska A, Lange S, et al. Nicotine Withdrawal Syndrome in Intensive Care Patients-Preventive and Therapeutic Implications. Medical sciences (Basel, Switzerland). 2026;14(3). doi:10.3390/medsci14030374

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.